Term Life Insurance: Integral part of your financial plan Term Life Insurance: Integral part of your financial plan Henil Shah / Friday, September 25, 2020 / Article rating: 4.3 Managing risk, be it in life or health-related, is crucial and becomes even more important when you actually invest your money to grow. Read on to find out more.
Sensex, Nifty rebound; Vodafone Idea zooms 14 per cent, Adani Green locks in at upper circuit Sensex, Nifty rebound; Vodafone Idea zooms 14 per cent, Adani Green locks in at upper circuit Geyatee Deshpande / Friday, September 25, 2020 / Article rating: 4.3 On Friday, the bears lost their week-long grip on the domestic markets, as the benchmark indices such as Sensex and Nifty rebounded to climb up high, closing in the green. Sensex soared by 835.06 points or 2.28 per cent to settle at 37,388.66 levels while Nifty zoomed by 244.70 points or 2.26 per cent to close at 11,050.25 level.
Dr Reddys Laboratories gains post launching Dexmedetomidine Hydrochloride in US market Dr Reddys Laboratories gains post launching Dexmedetomidine Hydrochloride in US market Chinmayee D / Friday, September 25, 2020 / Article rating: 3.8 Dr Reddy’s has launched the injection at an affordable price, making it readily available for patients. The company’s capacity to adequately supply Dexmedetomidine is significant as it's on the FDA’s drug shortage list.
Granules India hits record high; zooms 92 per cent in 3 months Granules India hits record high; zooms 92 per cent in 3 months Ganesh V / Friday, September 25, 2020 / Article rating: 4.4 Granules India Limited today announced that United States Food & Drug Administration (USFDA) has approved its abbreviated new drug application (ANDA) for Naproxen Sodium and Diphenhydramine Hydrochloride tablets, 220 mg/25 mg (OTC), which is a generic equivalent of Aleve PM Tablets, 220 mg/25 mg, of Bayer HealthCare LLC.
Vakrangee locks in at upper circuit; stock gains by more than 40 per cent from COVID-19 lows Vakrangee locks in at upper circuit; stock gains by more than 40 per cent from COVID-19 lows Geyatee Deshpande / Friday, September 25, 2020 / Article rating: 4.1 On Friday, the shares of Vakrangee Limited locked in at its upper circuit of 10 per cent at Rs 27.10 per share. The jump in the stock price was due to the company’s announcement about being granted an in-principle authorisation to set-up and operate the Bharat Bill Payment Operating Unit (BBPOU) by Reserve Bank of India (RBI).
Maurices partners with TCS to build greenfield IT ecosystem Maurices partners with TCS to build greenfield IT ecosystem Ganesh V / Friday, September 25, 2020 / Article rating: 3.6 Tata Consultancy Services (TCS), a leading global IT services, consulting, and business solutions organization, has partnered with Maurices, a women’s fashion-apparel retail chain in the US and Canada, to help create a new flexible and scalable IT landscape for the latter.
Five stocks with buying interest Five stocks with buying interest Ganesh Pawar / Friday, September 25, 2020 / Article rating: 3.7 The market opened in green on September 25, 2020, overall volumes in futures & options currently stand at 6,71,01,341 crore contracts with a turnover of Rs. 43,02,566.44 crore.
Ten stocks close to their 52-week high Ten stocks close to their 52-week high Ganesh Pawar / Friday, September 25, 2020 / Article rating: 2.6 The market opened in green on September 25, 2020.
Five stocks with selling interest Five stocks with selling interest Ganesh Pawar / Friday, September 25, 2020 / Article rating: 3.9 The market opened in green on September 25, 2020, overall volumes in futures & options currently stand at 6,71,01,341 crore contracts with a turnover of Rs. 43,02,566.44 crore.
Cipla gets final nod for generic therapeutic equivalent of Tecfidera; stock opens 1.52 per cent higher Cipla gets final nod for generic therapeutic equivalent of Tecfidera; stock opens 1.52 per cent higher Rishikesh Gaikwad / Friday, September 25, 2020 / Article rating: 3.4 Cipla Limited today announced that it has received final approval for its abbreviated new drug application (ANDA) for Dimethyl Fumarate DR Capsules 120mg, 240mg, and 120mg/240mg starter pack from United States Food & Drug Administration (USFDA).